Is diabetes a risk factor for malignancy post-transplant in liver transplant recipients?

Congly, Stephen E

Congly, Stephen E.

Affiliation

Congly SE; Divisions of Gastroenterology and Hepatology and Transplant Medicine, Department of Medicine, Cumming School of Medicine, O'Brien Institute of Public Health, University of Calgary, 6th Floor, Teaching Research and Wellness Building, 3280 Hospital Drive NW, Calgary AB T2N 4N1 Canada. Electronic address: secongly@ucalgary.ca.

Ann Hepatol ; 27(3): 100703, 2022.

Article de En | MEDLINE | ID: mdl-35338011

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transplantation hépatique / Diabète / Tumeurs Type d'étude: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Ann Hepatol Sujet du journal: GASTROENTEROLOGIA Année: 2022 Type de document: Article Pays de publication: Mexique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google